The greenshoe — formally the over-allotment option — is underwriters’ right to sell up to 15% more shares than an offering’s base size, purchasable from the issuer at the offering price for about 30 days after an IPO. Named for the 1963 Green Shoe Manufacturing deal that pioneered it, it is the mechanism behind post-IPO price stabilization.
How the mechanism works
Underwriters routinely sell 115% of the deal at pricing, going short the extra 15%. The short position becomes a stabilization tool with two clean exits. If the stock trades up, the syndicate exercises the greenshoe — buying the extra shares from the issuer at the offering price to cover the short — and the deal simply ends 15% larger. If the stock trades down, the syndicate covers by buying shares in the open market instead, and that buying supports the price near the offering level; the issuer sells only the base deal. Either way the short is closed without risk to the underwriters, which is the design’s elegance: stabilization firepower that costs nothing and requires no prediction. For fund investors reading exit outcomes, the practical footnotes: “shoe exercised in full” signals a well-received deal (and slightly more proceeds/dilution than the base size implied), while heavy stabilization suggests a strained one — and sponsor sell-downs in portfolio-company IPOs size against the post-shoe share count. The underwriting discount applies to shoe shares as to base shares.
Related terms
Initial Public Offering (IPO) · Underwriting Discount · Firm-Commitment Offering · Lock-Up Period
Educational content only; not investment, tax, or legal advice. Consult qualified professionals regarding your specific circumstances.
